Association of plasma biomarkers with longitudinal change in age‐ and Alzheimer’s disease‐related brain atrophy patterns

Abstract

Background: Demonstrating the specificity of plasma biomarkers to AD‐related neurodegeneration would add support to their prognostic and diagnostic clinical use.